Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
A synthetic 15-amino-acid sequence derived from a protective compound in gastric juice, it shows consistent results across animal studies for tendon, ligament, muscle, bone, and GI tissue repair through angiogenesis, collagen organization, and inflammation control
9,11 Some evidence suggests that maternal stress may contribute to an increased occurrence of ASD traits
S.AlvianoC
02 COMPLETE INTAKE & CONSENT FORM Please complete this form at least 48 hours before your appointment time